Molecule- SPK-DJ29

SPK-DJ29 (SPK9)

Biological activity:

1. Inhibits TLK1 kinase activity by 60%.
2. Inhibits cellular TLK1 by reduced phosphorylation levels of pRad9 at 5 µM.
3. Cytotoxic towards Prostate cancer and Glioblastoma.
LNCaP- 3.8µM
DU145-19.1 µM
LN227-14.1 µM
4. Suppresses colony formation ability of LNCaP cells when administered along with Bicalutamide.

Biological activity:

Molecular Weight 477.58 g/mol
Appearance White Solid
Storage 20ºC for long term, 4ºC for short term use
Solubility 50 mM in DMSO
Stability Solid stable up to 2.5 years after synthesis
en_USEnglish